RGM Capital’s Bio-Techne TECH Stock Holding History

RGM Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,152,052	Closed	-$127M	–	13
2025 Q4	$127M	Sell	2,152,052 -148,000	-6%	-$8.99M	6.14%	8
2025 Q3	$128M	Buy	2,300,052 +100,000	+5%	+$5.36M	5.39%	12
2025 Q2	$113M	Buy	2,200,052 +1,189,192	+118%	+$59.8M	4.58%	13
2025 Q1	$59.3M	Buy	+1,010,860	New	+$68.5M	2.46%	18

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RGM Capital's TECH Position: Q1 2026 in Review

RGM Capital sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 2,152,052 shares — an estimated $127M sold.

RGM Capital first reported a position in TECH in Q1 2025 and held it in 4 quarters. The position peaked at $128M in Q3 2025. 585 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

RGM Capital reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
RGM Capital sold 2,152,052 Bio-Techne shares in Q1 2026, an estimated $127M.
RGM Capital first reported a position in Bio-Techne in Q1 2025 and held it in 4 quarters.
RGM Capital's Bio-Techne position peaked at $128M in Q3 2025.
585 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on RGM Capital's 13F filing for Q1 2026.